Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

A multicentre, randomised, double-blind, 90-day superiority trial to evaluate the effect on clinical benefit, safety and tolerability of once daily oral Empagliflozin 10mg compared to placebo, initiated in patients hospitalised for acute heart failure who have been stabilised(EMPULSE) www.ClinicalTrials.gov : NCT04157751

Projekt: Typer af projekterProjekt

Vis graf over relationer
StatusIgangværende
Periode01/10/2020 → …

ID: 61755538